(NASDAQ: ALEC) Alector's forecast annual revenue growth rate of 2.02% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 82.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.57%.
Alector's revenue in 2025 is $81,130,000.On average, 4 Wall Street analysts forecast ALEC's revenue for 2025 to be $1,737,005,990, with the lowest ALEC revenue forecast at $1,619,397,264, and the highest ALEC revenue forecast at $1,877,286,278. On average, 4 Wall Street analysts forecast ALEC's revenue for 2026 to be $1,995,603,491, with the lowest ALEC revenue forecast at $426,103,905, and the highest ALEC revenue forecast at $4,048,493,160.
In 2027, ALEC is forecast to generate $10,441,772,346 in revenue, with the lowest revenue forecast at $3,360,451,747 and the highest revenue forecast at $23,541,987,725.